Wednesday, February 24, 3:30-5 p.m. in the Marburg Conference Room
“Testosterone and 'Age-Related Hypogonadism' - FDA Concerns”
- Hylton Joffe, director, Division of Bone, Reproductive and Urologic Products, FDA
- Mohamed Mohamoud, team leader, Drug Utilization Team, Division of Epidemiology, FDA
- Trung-Hieu Brian Tran, regulatory review officer, Office of Prescription Drug Promotion
- Mark Hirsch, clinical team leader, Division of Bone, Reproductive and Urologic Products, FDA
- David Moeny, deputy director, Division of Epidemiology II, FDA
- Christine Nguyen, deputy director for safety, Division of Bone, Reproductive and Urologic Products, FDA
